With a strong product portfolio, this growth and income stock is an excellent long-term investment.
Although Abbvie stock has been lagging behind the broader market over the past year, Wall Street analysts are still moderately bullish about its outlook.
AbbVie's returns haven't been great this year, but investors shouldn't overlook this promising growth stock.
These dividend stocks are ideal for investors seeking long-term passive income.
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END
This company offers growth, high yield, and dividend growth.
This pharma giant just made a smart strategic acquisition.
Revenue growth during what should be a disastrous patent cliff is encouraging.
All 10 of these stocks pay reliable and growing dividends.